News (29)

Transcript : Argenx SE, Q1 2024 Earnings Call, May 09, 2024
Transcript : Argenx SE, Q4 2023 Earnings Call, Feb 29, 2024
Transcript : Argenx SE - Special Call
Transcript : Argenx SE, Q3 2023 Earnings Call, Oct 31, 2023
Transcript : Argenx SE Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-11-2023 12:55 PM
Transcript : Argenx SE Presents at Citi 18th Annual BioPharma Conference, Sep-06-2023 04:20 PM
Transcript : Argenx SE, Q2 2023 Earnings Call, Jul 27, 2023
Transcript : Argenx SE - Special Call
Transcript : Argenx SE - Special Call
Transcript : Argenx SE Presents at Bank of America Securities 2023 Healthcare Conference, May-09-2023 08:00 AM
Transcript : Argenx SE, Q1 2023 Earnings Call, May 04, 2023
Transcript : Argenx SE, Q4 2022 Earnings Call, Mar 02, 2023
Transcript : Argenx SE Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-09-2023 09:00 AM
Transcript : Argenx SE Presents at Piper Sandler 34th Annual Healthcare Conference, Nov-30-2022 01:00 PM
Transcript : Argenx SE Presents at 5th Annual Evercore ISI HealthCONx Conference 2022, Nov-29-2022 10:55 AM
Transcript : Argenx SE, Q3 2022 Earnings Call, Oct 27, 2022
Transcript : Argenx SE, H1 2022 Earnings Call, Jul 28, 2022
Transcript : Argenx SE, Q1 2022 Earnings Call, May 05, 2022
Transcript : Argenx SE Presents at 42nd Annual Cowen Health Care Conference, Mar-07-2022 02:10 PM
Transcript : Argenx SE, Q4 2021 Earnings Call, Mar 03, 2022
Transcript : argenx SE Presents at JPMorgan 40th Annual Healthcare Conference, Jan-10-2022 07:30 AM
Transcript : argenx SE - Special Call
Transcript : argenx SE, Q3 2021 Earnings Call, Oct 28, 2021
Transcript : argenx SE, H1 2021 Earnings Call, Jul 29, 2021
Transcript : argenx SE - Special Call
Transcript : argenx SE Presents at Goldman Sachs 42nd Annual Global Healthcare Conference, Jun-08-2021 02:10 PM
Argenx : Appoints Karl Gubitz as Chief Financial Officer (Form 6-K) PU
Argenx Appoints Karl Gubitz as Chief Financial Officer GL
Argenx SE Announces Executive Changes CI

Companies (7)

G-III APPAREL GROUP, LTD. 1 279 M $
Logo G-III Apparel Group, Ltd.

G-III Apparel Group, Ltd. designs, sources and markets a range of apparel, including outerwear, dresses, sportswear, swimwear, women’s suits and women’s performance wear, as well as women’s handbags, footwear, small leather goods, cold weather acces ...

MEDNATION AG 5 M $
Logo MedNation AG

MedNation AG, formerly known as Eifelhoehen-Klinik AG, is a Germany-based company. The Company is engaged in facilitating outpatient and inpatient rehabilitation, geriatric care and outpatient medical care. It operates the Kaiser-Karl-Klinik GmbH in Bonn, ...

PT GOLDEN FLOWER TBK 21 M $
Logo PT Golden Flower Tbk

PT Golden Flower Tbk is an Indonesia-based integrated apparel manufacturing company. The Company is a garment manufacturers and exporters in Indonesia. The Company manufactures light to medium weight woven apparels, including ladies blouse, men’s shirt, ...

INTERPARFUMS 3 645 M $
Logo Interparfums

Interparfums specializes in the design, manufacturing and marketing of luxury fragrances. The group's activity is organized primarily around 2 product families: - fragrance: Montblanc, Jimmy Choo, Coach, Lanvin, Rochas, Boucheron, Karl Lagerfeld, Van Cle ...

DAEJUNG CHEMICALS & METALS CO., LTD. 88 M $
Logo Daejung Chemicals & Metals Co., Ltd.

DAEJUNG CHEMICALS & METALS CO., LTD. is a Korea-based company mainly engaged in the provision of chemicals for reagents. The Company’s products portfolio consists of reagents, including general analytical reagents, high-purity reagents, reagents for mea ...

LINK PHARMA CHEM LIMITED 2 M $
Logo Link Pharma Chem Limited

Link Pharma Chem Limited is an India-based chemical manufacturing company. The Company is engaged in the manufacturing and selling of organic intermediates which are used in the pharmaceuticals, agro and specialty chemical industries. The Company is also ...

INTER PARFUMS, INC. 3 920 M $
Logo Inter Parfums, Inc.

Inter Parfums, Inc. manufactures, markets and distributes a range of fragrance and fragrance related products. The Company has two segments. The Company produces and distributes its fragrance products under license agreements with brand owners, and fragra ...


Insiders

Picture Karl Gubitz
Karl Gubitz

Karl Gubitz holds the position of Chief Financial Officer of argenx SE. Mr. Gubitz received an MBA from Henley Management College, an undergraduate degree from the University of South Africa and an undergraduate degree from the University of Pretoria.




Picture Gregory Gubitz
Gregory Gubitz

Gregory Gubitz was the founder of HLS Therapeutics, Inc. (founded in 2014) where he held the titles of Chief Executive Officer & Director and Chairman.
He is currently the Chief Executive Officer of Grosvenor Ventures Ltd.
(since 2007), Chairman of Big Life Foundation Canada, and Director of HydRx Farms Ltd.
Mr. Gubitz's former positions include Independent Director at Telesta Therapeutics, Inc. (2013-2014), Director at BIOTECanada, Independent Director at biOasis Technologies, Inc. (2012-2017), Senior VP-Corporate Development & General Counsel at Biovail Corp.
(2006-2010), and Chief Operating Officer at Lumira Capital Investment Management, Inc. (2003-2006).
He was also a Partner at Fasken Martineau DuMoulin LLP.
Mr. Gubitz received his undergraduate degree from McGill University in 1984 and his graduate degree from the same institution.






No results for this search